Comorbidity and the concentration of healthcare expenditures in older patients with heart failure

Journal of the American Geriatrics Society

Volumn 51, Issue 4, 2003, Pages 476-482

  Zhang, James X ^a   Rathouz, Paul J ^b   Chin, Marshall H ^b  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

Comorbidity; Economic evaluation; Expenditures; Heart failure; Medicare

Indexed keywords

AGED; ARTICLE; COMORBIDITY; ELDERLY CARE; FEMALE; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH PROGRAM; HEALTH SERVICE; HEALTH SURVEY; HEART FAILURE; HEART INFARCTION; HEMIPLEGIA; HOSPITAL ADMISSION; HUMAN; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICARE; MULTIVARIATE ANALYSIS; PARAPLEGIA; PERIPHERAL VASCULAR DISEASE; PREVALENCE; REIMBURSEMENT; RETROSPECTIVE STUDY;

ACTIVITIES OF DAILY LIVING; AGED; AGED, 80 AND OVER; COMORBIDITY; FEMALE; GERIATRICS; HEALTH EXPENDITURES; HUMANS; MALE; MEDICARE; MYOCARDIAL INFARCTION; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; UNITED STATES;

EID: 0037393821     PISSN: 00028614     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1532-5415.2003.51155.x     Document Type: Article

References (41)

1. Hunt SA, Baker DW, Chin MH et al. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol 2001;38:2101-2113.
2. Goldberg RJ, Konstam MA. Assessing the population burden from heart failure: Need for sentinel population-based surveillance systems. Arch Intern Med 1999;159:15-17.
3. Kannel WB. The demographics of claudication and the aging of the American population. Vasc Med 1996;1:60-64.
4. Eriksson H. Heart failure. A growing public health problem. J Intern Med 1995;237:135-141.
5. O'Connell JB. The economic burden of heart failure. Clin Cardiol 2000;23(3 Suppl.):6-10.
6. Topol EJ, Mark DB, Lincoff AM et al. Outcomes at 1 year and economic implications of platelet glycoprotein IIb/IIIa blockade in patients undergoing coronary stenting: Results from a multicentre randomised trial. EPISTENT Investigators. Evaluation of Platelet IIb/IIIa Inhibitor for Stenting. Lancet 1999;11:2019-2024.
7. Andrews R, Cowley AJ. Clinical and economic factors in the treatment of congestive heart failure. Pharmacoeconomics 1995;7:119-127.
8. Szucs TD. Pharmacoeconomics of angiotensin converting enzyme inhibitors in heart failure. Am J Hypertens 1997;10:272S-279S.
9. Stroupe KT, Forthofer MM, Brater DC et al. Healthcare costs of patients with heart failure treated with torsemide or furosemide. Pharmacoeconomics 2000;17:429-440.
10. Noe LL, Vreeland MG, Pezzella SM et al. A pharmacoeconomic assessment of torsemide and furosemide in the treatment of patients with congestive heart failure. Clin Ther 1999;21:854-866.
11. Davey PG, Clarkson PB, McMahon A et al. Costs associated with symptomatic systolic heart failure. Pharmacoeconomics 1999;16:399-407.
12. Cleland JG. Health economic consequences of the pharmacological treatment of heart failure. Eur Heart J 1998; 19(Suppl. P):P32-P39.
13. Cook JR, Glick HA, Gerth W et al. The cost and cardioprotective effects of enalapril in hypertensive patients with left ventricular dysfunction. Am J Hypertens 1998;11:1433-1441.
14. Taylor DH Jr, Whellan DJ, Sloan FA. Effects of admission to a teaching hospital on the cost and quality of care for Medicare beneficiaries. N Engl J Med 1999;340:309-310.
15. Schulman KA, Mark DB, Califf RM. Outcomes and costs within a disease management program for advanced congestive heart failure. Am Heart J 1998;135(Suppl. 2):S285-S292.
16. O'Connor CM, Radensky PW, Unger AN et al. Hospital use and costs among patients with nonischemic cardiomyopathy in the first prospective randomized amlodipine survival evaluation study. Clin Ther 1999;21:1254-1265.
17. Ferraris VA, Ferraris SP, Singh A. Operative outcome and hospital cost. J Thorac Cardiovasc Surg 1998;115:593-603.
18. Wilson JR, Smith JS, Dahle KL et al. Impact of home health care on health care costs and hospitalization frequency in patients with heart failure. Am J Cardiol 1999;83:615-617.
19. Kornowski R, Zeeli D, Averbuch M et al. Intensive home-care surveillance prevents hospitalization and improves morbidity rates among elderly patients with severe congestive heart failure. Am Heart J 1995;129:762-766.
20. Anderson MA, Pena RA, Helms LB. Home care utilization by congestive heart failure patients: A pilot study. Public Health Nurs 1998;15:146-162.
21. Mackowiak J. Cost of heart failure to the healthcare system. Am J Manag Care 1998;4(6 Suppl.):S338-S342.
22. Ray GT, Collin F, Lieu T et al. The cost of health conditions in a health maintenance organization. Med Care Res Rev 2000;57:92-109.
23. Xuan J, Duong PT, Russo PA et al. The economic burden of congestive heart failure in a managed care population. Am J Manag Care 2000;6:693-700.
24. Harjai KJ, Boulos LM, Smart FW et al. Effects of caregiver specialty on cost and clinical outcomes following hospitalization for heart failure. Am J Cardiol 1998;82:82-85.
25. Chin MH, Wang JC, Zhang JX et al. Differences among geriatricians, general internists, and cardiologists in the care of patients with heart failure: A cautionary tale of quality assessment. J Am Geriatr Soc 1998;46:1349-1354.
26. Adler GS. A profile of the Medicare Current Beneficiary Survey. Health Care Financ Rev 1994;15:153-163.
27. The International Classification of Diseases, Ninth Revision, Clinical Modification, 5th Ed. Salt Lake City, UT: Medicode Publication, 1995.
28. Hebert PL, Geiss LS, Tierney EF et al. Identifying persons with diabetes using Medicare claims data. Am J Med Qual 1999;14:270-277.
29. Katz S, Ford AB, Moskowitz RW et al. Studies of illness in the aged. The Index of ADL. A standardized measure of biological and psychosocial function. JAMA 1963;185:914-919.
30. Lawton MP, Brody EM. Assessment of older people: Self-maintaining and instrumental activities of daily living. Gerontologist 1969;9:179-186.
31. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992;45: 613-619.
32. Romano PS, Roos LL, Jollis JG. Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: Differing perspectives. J Clin Epidemiol 1993;46:1075-1079.
33. Zhang JX, Iwashyna TJ, Christakis NA. The performance of different lookback periods and sources of information for Charlson Comorbidity adjustment in Medicare claims. Med Care 1999;37:1128-1139.
34. Cochran WG. Sampling Techniques, 3rd Ed. New York: John Wiley and Sons, 1977.
35. St. Anthony's DRG Guidebook 1999. Reston, VA: St Anthony's Publishing, 1999.
36. Ni H, Nauman DJ, Hershberger RE. Analysis of trends in hospitalizations for heart failure. J Card Fail 1999;5:79-84.
37. Rich MW, Beckham V, Wittenberg C et al. A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. N Engl J Med 1995;333:1190-1195.
38. Berk ML, Monheit AC. The concentration of health care expenditures, revisited. Health Aff 2000;20:9-18.
39. Health Care Financing Administration. Managed Care in Medicare and Medicaid. September 1996 [On-line]. Available at www.hcfa.gov/facts/n9609.htm Accessed April 24, 2002.
40. Jollis JG, Ancukiewicz M, DeLong ER et al. Discordance of databases designed for claims payment versus clinical information systems. Implications for outcomes research. Ann Intern Med 1993;119:844-850.
41. Psaty BM, Boineau R, Kuller LH et al. The potential costs of upcoding for heart failure in the United States. Am J Cardiol 1999;84:108-109.